← All Vaccine Summaries VAERS AE Overview · Global Data Sources · Open Source Medicine Foundation

Pharmacovigilance Lot Signal Detection — Hypothesis-Generating Only

VAERS lot-level analysis (U.S.) plus Canada Vigilance and other national systems (product-level). Data current as of 2026-10-28 · Methods · Schemas

⚠️ Critical Caveats — Read Before Interpreting

VAERS flags: VOL high report volume (z ≥ 3) · BURST clustered in <90 days · SER serious reports >50%

Pharmacovigilance systems covered — only VAERS provides lot-level fields in the public data used here.

SystemRegionLot dataNotes
VAERSUnited StatesLot dataLot-level signal tables on this page (VAX_LOT field; ~69% coverage).
Canada VigilanceCanadaNo public lot fieldPublic CV Online extract has no lot/batch field — product-level counts only.
JADER (PMDA, Japan)JapanNo public lot fieldJADER public CSV (demo/drug/reac/hist) — MedDRA/J terms; no lot field in open data.
Lareb (Netherlands)NetherlandsNo public lot fieldVaccine schema index with per-vaccine databank links (ATC-coded); no public bulk extract or lot field.
EudraVigilanceEuropean UnionNo public lot fieldPublic line listings are not lot-stratified.
VigiAccess (WHO)GlobalNo public lot fieldAggregate search only.
Yellow Card (UK)United KingdomNo public lot fieldiDAP reaction summaries; no public lot breakdown.
DAEN (Australia)AustraliaNo public lot fieldPublic search; lot not in open export.
VAERS analysis: 32,339 lots | 68.61% reports with usable lot | 2006–2026 | Generated 2026-10-28 18:38 UTC

COVID-19

719,502 VAERS lot-attributed reports | 6286 lots | 592 flagged

VAERS (United States) — full lot IDs

COVID-19 (primary series) — Moderna

317,925 reports | 3403 lots | 299 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
039K20A6,9796.3%15917.3VOL
013L20A5,5787.4%11113.8VOL
026L20A5,0146.7%6112.4VOL
011J20A4,7385.7%4611.7VOL
012L20A3,91113.6%2019.6VOL
004M20A3,8659.9%1189.5VOL
029L20A3,76710.4%889.2VOL
025L20A3,5517.3%918.7VOL
007M20A3,32011.5%988.1VOL
031L20A3,29314.6%1428.0VOL
027L20A3,2729.6%948.0VOL
041L20A3,2339.2%757.9VOL

COVID-19 (primary series) — Pfizer-BioNTech

322,602 reports | 2546 lots | 285 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
EK92314,3558.5%668.5VOL
EK57304,3165.7%258.4VOL
ER26134,14320.0%1048.1VOL
EH98993,9956.3%357.8VOL
EN62013,86228.5%2807.5VOL
EN53183,59023.2%2277.0VOL
EN62053,54021.9%1406.9VOL
EN62073,49626.3%1496.8VOL
ER87323,47921.7%876.8VOL
EN62003,36228.3%2236.5VOL
EN62083,33120.9%1086.5VOL
ER87333,32817.3%656.5VOL

COVID-19 (primary series) — Janssen (J&J)

45,594 reports | 370 lots | 50 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
043A21A2,99014.1%1036.9VOL
042A21A2,86516.6%796.6VOL
202A21A2,12710.0%424.8VOL
201A21A2,08312.2%364.7VOL
205A21A1,91715.4%584.3VOL
203A21A1,88612.2%344.3VOL
18050181,88516.3%444.2VOL
206A21A1,84113.1%264.2VOL
18050221,79712.1%364.0VOL
18050291,69719.3%453.8VOL
207A21A1,47212.6%293.3VOL
041A21A1,44913.5%533.2VOL

COVID-19 (additional/booster) — Pfizer-BioNTech

17,936 reports | 194 lots | 30 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
GH96931,85914.5%166.4VOL
GH97021,44317.9%84.9VOL
GJ25241,3629.0%54.6VOL
GH96941,3509.0%134.5VOL
GJ66651,2678.1%114.2VOL
GK16571,1610.8%03.9VOL
GJ327772853.0%72.3SER
6J6742100.0%0-0.3BURST
FP7150100.0%0-0.3BURST
LM2211100.0%0-0.3BURST
LM2216100.0%0-0.3BURST
LM222190.0%0-0.3BURST

COVID-19 (additional/booster) — Moderna

12,434 reports | 260 lots | 23 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
AS7147B6162.6%16.3VOL
AS7140C4834.1%04.9VOL
AS7146B4172.9%14.1VOL
AS7143C3929.4%13.9VOL
AS7144B3877.8%43.8VOL
AS7148B36010.8%23.5VOL
216K22A3550.8%03.4VOL
AS7664B330.0%0-0.2BURST
261K22A230.0%0-0.3BURST
AS7647B180.0%0-0.3BURST
05D22A160.0%0-0.4BURST
204H23-2A147.1%0-0.4BURST

COVID-19 (primary series)

547 reports | 65 lots | 10 flagged · showing 10

Lot IDReportsSerious%DeathszFlags
1805018348.8%03.8VOL
1802068220.0%02.0BURST
18089781513.3%11.0BURST
305273490.0%00.1BURST
6315MF002C90.0%00.1BURST
814636790.0%00.1BURST
8146743633.3%0-0.4BURST
UKNOWN580.0%0-0.5SER
031M20A366.7%0-0.8SER
COVID3100.0%1-0.8SER

COVID-19 (primary series) — Novavax

367 reports | 18 lots | 2 flagged · showing 2

Lot IDReportsSerious%DeathszFlags
4302MF0231527.9%03.9VOL
4302MF02130.0%0-0.2BURST

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
3032707Manufacturing product shipping issue28127357.472334766.5837390038.8077
HM7010Product identification number issue1147545.758652777.956957471.0993
026B12AMultiple use of single-use product726516.94183336.8147121588.7529
8363700003Product label confusion4317172.2724515139.1728355837.7482
026B12AHepatitis B virus test48064.05613646.171822029.2802
026B12AHepatitis C virus test57417.453614833.907227483.8138
AU5552BManufacturing issue35709.57145921.06618.7669
FL2757Recalled product administered565105.92285393.344933159.4081
026B12AHIV test63308.59898086.241716234.7402
AU5509BProduct packaging quantity issue93281.70833566.335916930.3363
031322Product label confusion33128.23484812.13046015.7
AU5550BProduct label issue63009.39123918.904913205.5145
E19126Vaccination site haemorrhage32921.403723364.22976873.0868
AU5551BProduct dispensing error102375.32452602.999515141.8438
3046731Device issue42196.45182446.56665533.4663

Canada Vigilance (Health Canada)

12,929 unique reports · 60,469 reaction mentions · 85.6% serious (11,070 of 12,929 reports). Top categories: Other / Unclassified (14,666), Cardiac / Cardiovascular (8,515), Neurological (7,715).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

31,435 unique reports · 125,347 reaction mentions · 10.9% serious (3,431 of 31,435 reports). Top categories: Other / Unclassified (41,031), Neurological (16,702), General / Systemic (non-local) (15,564).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

No EudraVigilance summary mapped for this vaccine.

Influenza

75,707 VAERS lot-attributed reports | 6689 lots | 1591 flagged

VAERS (United States) — full lot IDs

Influenza (trivalent) — Sanofi Pasteur

24,583 reports | 1879 lots | 536 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
U4713AA8726.4%16.6VOL
U5041BA8122.2%06.1VOL
U3599AA7424.3%05.4VOL
U4714AA7339.7%05.3VOL
U5024CA7320.5%25.3VOL
UI808AA6516.9%24.6VOL
UI808AB6311.1%04.5VOL
UI993AB630.0%04.5VOL
U3602AA6240.3%14.4VOL
U4715AA6237.1%04.4VOL
U5017AA6230.6%04.4VOL
U4764AA6028.3%04.2VOL

Influenza (quadrivalent) — Sanofi Pasteur

12,663 reports | 1344 lots | 284 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
UT7683NA780.0%010.6VOL
UI669AA5578.2%07.0VOL SER
UJ875AE550.0%07.0VOL BURST
UI212AA412.4%04.9VOL
UJ461AB390.0%04.5VOL
UJ505AA390.0%04.5VOL
UI980AB372.7%04.2VOL BURST
UJ499AB370.0%04.2VOL
U8132DA360.0%04.1VOL
UI158AA3633.3%04.1VOL
UI810AA362.8%04.1VOL
UJ460AB355.7%03.9VOL

Influenza (trivalent) — Novartis Vaccines And Diagnostics

9,274 reports | 793 lots | 216 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
1457012300.4%014.5VOL
15145011325.3%08.0VOL
15157011281.6%07.7VOL
14511P1012.0%05.9VOL
111774P18431.0%04.8VOL
111775P17227.8%04.0VOL
11002017035.7%23.9VOL
97839P26631.8%03.6VOL
111776P16341.3%03.4VOL
111770P16235.5%03.3VOL
97841P15729.8%03.0VOL
98447P12835.7%01.1BURST

Influenza (trivalent) — Glaxosmithkline Biologicals

5,302 reports | 651 lots | 210 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
AFLUA3508A812.5%011.8VOL
AFLLA598AA4436.4%05.8VOL
K9XL5392.6%15.0VOL
AFLUA3168A380.0%04.8VOL BURST
AFLUA316BA3321.2%04.0VOL
4D255300.0%03.5VOL
AFLLA738AA2828.6%03.2VOL
AFLLA259AA2657.7%02.9SER
AFLLA686AA2653.8%02.9SER
ALFUA319AA22100.0%02.2BURST SER
AFLLA261AA2171.4%02.1SER
AFLLA615AA2065.0%01.9SER

Influenza (quadrivalent) — Glaxosmithkline Biologicals

9,236 reports | 843 lots | 143 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
Z72751210.0%012.0VOL
5RS7Z890.0%08.5VOL
5RS72600.0%05.3VOL
PN75E555.5%04.8VOL
Y7X9Z4930.6%04.2VOL
5GC54464.3%03.8VOL
5J594458.9%03.7VOL
9M3F7449.1%03.6VOL
JL59K434.7%03.5VOL
5255R4027.5%03.2VOL
359MH3933.3%03.1VOL
Y79A5392.6%03.1VOL

Influenza (trivalent) — Csl Limited

4,462 reports | 505 lots | 138 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
11049221A7397.3%08.3VOL SER
WT54306731.4%08.3VOL
14649211A680.0%07.7VOL
T50507472.1%04.9VOL
U55406402.5%04.0VOL
WT53706390.0%03.9VOL
U551063718.9%03.6VOL
03149111A352.9%03.4VOL BURST
R531072454.2%02.0SER
WT53206219.5%01.6BURST
13849121A1952.6%01.3SER
03549111A1618.8%00.9BURST

Influenza (quadrivalent) — Seqirus, Inc.

2,094 reports | 333 lots | 41 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
P100359452690.0%010.8VOL
NOBATCHNUMBER643.1%09.9VOL
00644623A244.2%03.0VOL
P100362830210.0%02.5BURST
14649211A160.0%01.7BURST
P100230206137.7%01.2BURST
YF37706119.1%00.8BURST
P100100560100.0%00.6BURST
P100112490100.0%00.6BURST
P100230202100.0%00.6BURST
AU1065C911.1%00.5BURST
P10024944990.0%00.5BURST

Influenza (trivalent) — Seqirus, Inc.

1,419 reports | 204 lots | 40 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
388477580.0%07.6VOL
388459490.0%06.3VOL BURST
388488424.8%05.2VOL BURST
388489330.0%03.9VOL
388478277.4%03.0VOL
946588230.0%02.4BURST
388466120.0%00.8BURST
407981120.0%00.8BURST
388473110.0%00.6BURST
388481100.0%00.5BURST
407247100.0%00.5BURST
40698690.0%00.3BURST

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
UI740AAProduct label confusion448661.071471710.578917831.8268
YK2207Palmar-plantar erythrodysaesthesia syndrome335323.866746074.304311263.4523
252664Foetal non-stress test normal325234.050467.019712.9687
11049221AHIV antigen negative5020646.310865011.76648849.1851
11049221AMultiple use of single-use product7020587.9054435267.068614.7849
NH3062Interchange of vaccine products317664.033342392.2818924.2499
AFLLA165AAHeat rash610813.714321626.428621199.8515
BB222Product substitution error39813.351923550.644413516.2499
11049221AHepatitis B surface antigen negative519570.522131474.094947208.3686
724TFProduct storage issue59252.120559.018922.2497
252664Complication of pregnancy38411.333316821.666711262.8571
UT7073JASoft tissue disorder38152.738527173.461513140.8333
AFLUA3168AAccidental overdose387863.1444613248.263259601.6477
11049221AHIV antibody negative517018.382923080.392645578.2139
80956No adverse reaction86807.915311436.617817736.3274

Canada Vigilance (Health Canada)

2,244 unique reports · 13,174 reaction mentions · 59.7% serious (1,340 of 2,244 reports). Top categories: Other / Unclassified (2,727), General / Systemic (non-local) (1,860), Neurological (1,423).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

3,723 unique reports · 5,903 reaction mentions · 10.6% serious (395 of 3,723 reports). Top categories: Other / Unclassified (1,264), Neurological (1,225), General / Systemic (non-local) (946).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

No EudraVigilance summary mapped for this vaccine.

Varicella

59,963 VAERS lot-attributed reports | 4500 lots | 503 flagged

VAERS (United States) — full lot IDs

Varivax — Merck

14,686 reports | 2089 lots | 335 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
N0229792480.0%028.1VOL
U029621970.0%010.5VOL
K007979881.1%09.4VOL BURST
L024256790.0%08.4VOL
K005180721.4%07.6VOL
M000996660.0%06.9VOL
M027885611.6%06.3VOL
M042858541.9%05.5VOL
L008270520.0%05.2VOL
M035142513.9%05.1VOL
N012132476.4%04.7VOL
L000454450.0%04.4VOL

Shingrix / varicella-zoster — Merck

17,398 reports | 1011 lots | 90 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
000064963416822.1%06.0VOL
H0199995416.7%04.4VOL
L024997529.6%04.1VOL
0622F5166.7%04.0VOL SER
J0017004926.5%03.8VOL
1604AA4810.4%03.7VOL
0162U4555.6%03.3VOL SER
0033U3775.7%02.4SER
0744U3658.3%02.2SER
0619U3557.1%02.1SER
0015U3461.8%12.0SER
0290U3464.7%02.0SER

Shingrix / varicella-zoster — Glaxosmithkline Biologicals

27,536 reports | 1371 lots | 57 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
58160-0823-115652.7%121.3VOL
B5EK217212.2%06.0VOL
CH2X71659.7%15.7VOL
539A21488.8%05.0VOL
3Z4KL1426.3%14.8VOL
4492P1366.6%04.5VOL
B97391341.5%04.5VOL
32GR41303.1%04.3VOL
HG4P31266.3%04.2VOL
LT5331267.1%04.2VOL
5NY3B1215.8%04.0VOL
NX95211810.2%13.8VOL

Shingrix / varicella-zoster

46 reports | 3 lots | 1 flagged · showing 1

Lot IDReportsSerious%DeathszFlags
7KG39370.0%01.1BURST

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
1504FPoor quality drug administered317487.458331088.03713382.0535
9LH3YProduct dispensing error176298.738711950.555621581.3414
9LH3YRecalled product administered182853.71435706.428618202.3649
T022314Vaccination site cellulitis52586.07844082.70286665.7115
TT2JFRecalled product administered82259.90699940.190212038.7714
K000782Incorrect product formulation administered82177.77997464.245411348.8248
L008273Neurological examination normal31195.62391635.74851947.8332
T017688Product temperature excursion issue4885.87191127.20062034.7029
J2N44Facial paresis3847.83431243.02371494.9517
K009770Hepatic enzyme increased3762.9109907.05621185.4589
1406FNo adverse effect3630.8421700.8246914.2589
K9L3MProduct complaint3505.6446777.3763942.225
X017487Pregnancy test positive3499.6417887.4741969.434
J2N44Ear discomfort3428.6803628.2644793.142
M034766Blindness3302.5393370.6288529.3734

Canada Vigilance (Health Canada)

3,417 unique reports · 11,067 reaction mentions · 64.0% serious (2,186 of 3,417 reports). Top categories: Other / Unclassified (2,726), General / Systemic (non-local) (1,881), Injection-site / Local reaction (1,854).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

666 unique reports · 1,313 reaction mentions · 8.1% serious (54 of 666 reports). Top categories: Other / Unclassified (459), Neurological (235), General / Systemic (non-local) (176).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

No EudraVigilance summary mapped for this vaccine.

Pneumococcal

31,003 VAERS lot-attributed reports | 1519 lots | 240 flagged

VAERS (United States) — full lot IDs

Pneumovax 23 — Merck

21,578 reports | 928 lots | 174 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
L0401781245.6%05.1VOL
K00726212314.6%05.0VOL
K0078221202.5%04.9VOL
L0023101127.1%04.5VOL
K00987410711.2%04.2VOL
L0077201027.8%04.0VOL
J0096899913.1%03.8VOL
J0098279821.4%03.8VOL
K0091059617.7%03.7VOL
N0039979113.2%03.4VOL
N010105897.9%03.3VOL
K012424839.6%03.0VOL

Prevnar 13 — Pfizer/Wyeth

6,295 reports | 424 lots | 50 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
G94060650.0%03.9VOL BURST
M130675827.6%03.4VOL
M069005728.1%03.3VOL
N979355424.1%03.1VOL
M357634652.2%02.4SER
M609933751.4%11.7SER
L135182356.5%00.6SER
G98820210.0%00.5BURST
J805271947.4%10.3BURST
L742511662.5%00.1SER
J498491560.0%00.0SER
N4385150.0%00.0BURST

Prevnar 20 — Pfizer/Wyeth

2,779 reports | 145 lots | 8 flagged · showing 8

Lot IDReportsSerious%DeathszFlags
LX4482610.0%03.4VOL
LN4932160.0%0-0.3BURST
MK8118110.0%0-0.7BURST
MN074990.0%0-0.8BURST
FJ259880.0%0-0.9BURST
MM052780.0%0-0.9BURST
MG7421714.3%1-1.0BURST
LP494660.0%0-1.1BURST

PNC — Pfizer/Wyeth

23 reports | 7 lots | 2 flagged · showing 2

Lot IDReportsSerious%DeathszFlags
B08692A366.7%0-0.6SER
D07543366.7%0-0.6SER

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
S036495Recalled product administered1514531.954518991.95056673.7643
0882FOverdose32892.43772.39132764.8215
0756AEPhlebitis32855.355322835.84215380.0692
1040PNonspecific reaction42846.11224193.7974169.1728
HF1068Poor quality product administered3761.0596932.6861072.4672
N4385Adverse reaction15504.547816114.52945860.2671
0756AEAbasia3488.75453903.0361110.8045
T024556Product administration error3387.3625495.544641.6297
0512PFluid retention5349.5179447.81791082.6433
HF1068Needle issue3326.1684399.5935533.9123
0621YNo reaction on previous exposure to drug3282.8475386.686500.3284
EW2019Product quality issue3273.5738373.9957485.0316
L74251Computerised tomogram head3231.9957291.8835399.2926
G94060Incorrect storage of drug65206.765127161.98999270.4553
0620FInjection site streaking37196.6438429.5534936.2308

Canada Vigilance (Health Canada)

797 unique reports · 3,089 reaction mentions · 59.5% serious (474 of 797 reports). Top categories: Other / Unclassified (649), Injection-site / Local reaction (542), Respiratory (397).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

2,068 unique reports · 4,585 reaction mentions · 5.8% serious (120 of 2,068 reports). Top categories: General / Systemic (non-local) (1,254), Other / Unclassified (908), Respiratory (852).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

No EudraVigilance summary mapped for this vaccine.

DTaP

27,631 VAERS lot-attributed reports | 2517 lots | 331 flagged

VAERS (United States) — full lot IDs

Tdap — Sanofi Pasteur

10,745 reports | 733 lots | 80 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
U4612AA6314.3%04.6VOL
C2730AA6238.7%04.5VOL
C2491AA5939.0%04.2VOL
C2340AA5822.4%04.1VOL
C2734AA5834.5%04.1VOL
C2631AA5133.3%03.5VOL
C2456AA5044.0%03.4VOL
C2610AA4835.4%03.2VOL
C2457AA4734.0%03.1VOL
C2688AA4740.4%03.1VOL
U4384AA3161.3%01.6SER
C2965AA2458.3%00.9SER

Tdap — Glaxosmithkline Biologicals

5,446 reports | 543 lots | 56 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
L5229460.0%05.1VOL
H4K3S446.8%14.8VOL
37R35342.9%03.4VOL
GC5NG320.0%03.1VOL
AC52B031AB2157.1%01.6SER
7RJ9B1952.6%01.3SER
AC52B066AA1752.9%01.0SER
JX5K9150.0%00.7BURST
KJ4MS1361.5%00.4SER
AC52B085AA1258.3%00.3SER
AC52B092FA1154.5%00.1SER
T25EG1154.5%00.1SER

DTaP — Sanofi Pasteur

2,121 reports | 252 lots | 48 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
C5893AA510.0%05.8VOL
C5367AA500.0%05.6VOL
3CA55C1330.0%03.3VOL
C3082AA1258.3%00.5SER
C2999AA1154.5%00.3SER
C3474AA1190.9%00.3SER
C3618AA1172.7%00.3SER
C2651AA100.0%00.2BURST
C4050AA1060.0%00.2SER
C4754AA1060.0%00.2SER
4CA34C190.0%00.1BURST
C3191AA966.7%00.1SER

Td — Sanofi Pasteur

1,025 reports | 135 lots | 26 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
U7183AA590.0%06.4VOL
U6922AA333.0%03.2VOL
U7092AA330.0%03.2VOL
A123B280.0%00.1BURST
C4153AA757.1%0-0.1SER
U3005BA757.1%0-0.1SER
U4852AA683.3%0-0.2SER
U2078BA580.0%0-0.3SER
U2348BA560.0%0-0.3SER
U1786BA475.0%0-0.5SER
U4669AA475.0%0-0.5SER
C4403BA3100.0%1-0.6SER

DTaP — Glaxosmithkline Biologicals

1,790 reports | 171 lots | 25 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
7KM94630.0%05.0VOL
7EC55521.9%04.0VOL
49TM3500.0%03.8VOL
Y4259430.0%03.1VOL
7C9NJ420.0%03.0VOL
AC14B126AA1070.0%0-0.0SER
4AC7A728.6%0-0.3BURST
AC14B056CA785.7%0-0.3SER
AC14B080AA757.1%0-0.3SER
AC14B101AA757.1%0-0.3SER
AC14B118AA757.1%0-0.3SER
AC14B006AA666.7%0-0.4SER

DTAPIPVHIB — Sanofi Pasteur

1,079 reports | 238 lots | 15 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
UJ973AA140.0%04.7VOL
UJ678AAA110.0%03.2VOL BURST
UJ983AA110.0%03.2VOL
C5507AA90.0%02.2BURST
UJ957AB80.0%01.7BURST
UK225AB70.0%01.2BURST
C3930AA683.3%00.7SER
UJ350AAA60.0%00.7BURST
UJ682AAA60.0%00.7BURST
C4131AA4100.0%0-0.3SER
C3603AA366.7%0-0.8SER
C3670AA3100.0%0-0.8SER

DTAPIPV — Glaxosmithkline Biologicals

2,739 reports | 158 lots | 14 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
34MF91370.7%05.8VOL
5H95B1021.0%04.1VOL
2KL4K800.0%03.0VOL
AC20B178CB2060.0%00.1SER
AC20B141BA1758.8%0-0.0SER
AC20B114CB1154.5%0-0.3SER
KB75Z1010.0%0-0.3BURST
AC20B137AA757.1%0-0.5SER
AC20B172AA560.0%0-0.6SER
AC20B193BA560.0%0-0.6SER
AC20B221BC560.0%0-0.6SER
AC20B184CA475.0%0-0.6SER

Td — Mass. Pub Hlth Biol Lab

300 reports | 55 lots | 14 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
A146A500.0%06.9VOL
A028A988.9%00.6SER
TD156955.6%00.6SER
TD171862.5%00.4SER
TD181757.1%00.2SER
A052A6100.0%00.1SER
TD-165580.0%0-0.1SER
TD157580.0%0-0.1SER
A015A366.7%0-0.4SER
A019A3100.0%0-0.4SER
A061B3100.0%0-0.4SER
A071A3100.0%0-0.4SER

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
U6855AAOphthalmic migraine317979.818226369.93335885.8331
U7276AABlood donor45650.08071.04942.3496
C2456AHepatitis B surface antigen negative54933.587312684.79598938.6517
U6855AAVestibular disorder33595.96365273.61333529.7499
C2456ARubella immunity confirmed33139.55565136.81823676.9009
C2456AAntibody test negative52302.34075918.73335956.9446
DTPA531A2Autism51918.82123014.85196355.3494
KB75ZNonspecific reaction31634.52892396.84242204.4534
C2456AHIV test negative51501.52663859.49694466.0912
C2456ASyphilis test negative31465.12592396.84242204.4534
22MS7Device connection issue31284.13641711.84851694.7603
U1813BANo adverse effect41130.242259.482700.1544
C2456AFoetal disorder4807.31431613.62862055.9588
99A7MIncorrect product storage8492.0421048.55632779.342
4233KIncorrect product storage4460.7121051.77021296.659

Canada Vigilance (Health Canada)

7,886 unique reports · 23,516 reaction mentions · 33.7% serious (2,658 of 7,886 reports). Top categories: General / Systemic (non-local) (6,335), Injection-site / Local reaction (3,651), Psychiatric / Neuropsychiatric (3,425).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

1,232 unique reports · 2,059 reaction mentions · 3.9% serious (48 of 1,232 reports). Top categories: Other / Unclassified (563), Respiratory (468), General / Systemic (non-local) (346).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

32,489 individual cases (up to 28/06/2026) · DIPHTHERIA, TETANUS AND PERTUSSIS (ACELLULAR, COMPONENT) VACCINE (ADSORBED). Reaction SOC breakdown not included in this DAP export.

Individual-case totals from adrreports.eu DAP exports in EudraVigilance/. Reaction SOC breakdown not included in these workbooks. Lot/batch numbers are not available.

Search EudraVigilance →

HPV

22,974 VAERS lot-attributed reports | 892 lots | 119 flagged

VAERS (United States) — full lot IDs

Gardasil (HPV4) — Merck

12,450 reports | 439 lots | 109 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
K0069602028.4%06.1VOL
K01021513511.9%03.7VOL
K0115621292.3%03.5VOL
1060U10763.6%12.8SER
1978U9950.5%22.5SER
0384U9863.3%02.4SER
0688F9764.9%02.4SER
0522U9062.2%02.2SER
0070X8855.7%02.1SER
1061U8856.8%02.1SER
0955F8366.3%11.9SER
0389U7959.5%21.8SER

Gardasil 9 (HPV9) — Merck

10,257 reports | 486 lots | 9 flagged · showing 9

Lot IDReportsSerious%DeathszFlags
17808761810.0%06.8VOL
17758271780.6%06.7VOL
17758111760.6%16.6VOL
N0047981741.1%06.5VOL
W0098291640.0%06.1VOL
U0326811570.0%05.8VOL
Z00888070.0%0-0.6BURST
M009362560.0%0-0.7SER
K0234323100.0%0-0.8SER

HPV2 — Glaxosmithkline Biologicals

57 reports | 9 lots | 1 flagged · showing 1

Lot IDReportsSerious%DeathszFlags
AHPVA117AA366.7%0-0.7SER

HPVX

29 reports | 1 lots | 1 flagged · showing 1

Lot IDReportsSerious%DeathszFlags
N000326290.0%00.0BURST

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
X024727Product label issue310715.133313975.95653416.2795
Y007322Product label issue37651.66679181.82390.5206
T026168Product distribution issue36178.84627139.84441911.8331
T039467Ill-defined disorder61179.40321643.62262864.8743
T026168Product temperature excursion issue81000.38461485.83437.0982
X024727Product lot number issue5990.47451563.32822550.1772
Y007322Product lot number issue5707.2969957.91841782.8926
1691180Product temperature excursion issue6348.6585407.35411044.6853
U032681Medication error39253.5333337.71113512.4108
W009829Medication error39242.7029318.77673360.2404
1775811Medication error39226.1294290.8033127.5388
1775827Medication error39223.5832286.60863091.8057
1780876Medication error39219.8689280.53783039.6866
0868FVaginitis bacterial3167.8464190.7469265.4673
90649Depression3159.997530.99345.1385

Canada Vigilance (Health Canada)

361 unique reports · 1,482 reaction mentions · 79.8% serious (288 of 361 reports). Top categories: Other / Unclassified (375), Neurological (275), General / Systemic (non-local) (182).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

3,198 unique reports · 13,421 reaction mentions · 1.1% serious (35 of 3,198 reports). Top categories: Neurological (4,219), Other / Unclassified (3,964), General / Systemic (non-local) (1,665).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

16,427 individual cases (up to 28/06/2026) · HUMAN PAPILLOMAVIRUS VACCINE [TYPES 6, 11, 16, 18, 31, 33, 45, 52, 58] (RECOMBINANT, ADSORBED). Reaction SOC breakdown not included in this DAP export.

Individual-case totals from adrreports.eu DAP exports in EudraVigilance/. Reaction SOC breakdown not included in these workbooks. Lot/batch numbers are not available.

Search EudraVigilance →

Hepatitis A

18,059 VAERS lot-attributed reports | 1725 lots | 168 flagged

VAERS (United States) — full lot IDs

HEP — Glaxosmithkline Biologicals

4,388 reports | 468 lots | 49 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
CP23D1210.0%013.3VOL
7NX57365.6%13.2VOL
AHBVC018BA1553.3%00.7SER
GSK955N2130.0%00.4BURST
AHBVB909AB955.6%0-0.0SER
AHBVB986AA966.7%0-0.0SER
AHBVC070BA80.0%0-0.2BURST
2FJ73785.7%0-0.3SER
AHBVB268CA757.1%0-0.3SER
C3TY3757.1%0-0.3SER
GSK9794C70.0%0-0.3BURST
SKBEP72470.0%0-0.3BURST

HEP — Merck

3,811 reports | 353 lots | 48 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
0385AE2720.0%012.5VOL
L0164272030.5%09.2VOL
L0257381330.8%05.8VOL
K020216841.2%03.5VOL
L010595750.0%03.1VOL
L001441140.0%00.1BURST
R001084110.0%00.0BURST
Y01250790.0%0-0.1BURST
0293AE771.4%1-0.2SER
0379U757.1%0-0.2SER
0570U757.1%0-0.2SER
1022F771.4%0-0.2SER

HEPA — Glaxosmithkline Biologicals

3,370 reports | 327 lots | 38 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
H4H53810.0%06.0VOL
KM72C720.0%05.3VOL
T9TL9660.0%04.8VOL
7YA99640.0%04.6VOL
772YT611.6%04.3VOL
2BA99590.0%04.2VOL
3J9G4512.0%03.5VOL
C2732180.0%00.7BURST
YL53290.0%0-0.1BURST
7KS9P80.0%0-0.2BURST
AHAVB242AA80.0%0-0.2BURST
AHAVB672AA875.0%0-0.2SER

HEPA — Merck

4,765 reports | 423 lots | 31 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
L018499890.0%06.9VOL
N005274722.8%05.4VOL
M039202690.0%05.1VOL
L015460657.7%04.8VOL
R018935590.0%04.2VOL
L023232563.6%04.0VOL
T013204530.0%03.7VOL
N017094520.0%03.6VOL
N008823500.0%03.4VOL
J005010464.3%03.1VOL
U012678170.0%00.5BURST
J011629110.0%0-0.0BURST

HEP — Dynavax Technologies Corporation

1,378 reports | 134 lots | 9 flagged · showing 9

Lot IDReportsSerious%DeathszFlags
933621380.0%03.7VOL
933841370.0%03.5VOL
935843340.0%03.1VOL
943187340.0%03.1VOL
946916100.0%0-0.0BURST
947357100.0%0-0.0BURST
94691370.0%0-0.4BURST
94735860.0%0-0.6BURST
94793160.0%0-0.6BURST

HEPA

10 reports | 2 lots | 1 flagged · showing 1

Lot IDReportsSerious%DeathszFlags
3397T70.0%00.0BURST

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
CP23DProduct dispensing error1156793.2934127487.123116715.0881
CP23DRecalled product administered1193904.755190504.244417032.0067
R022122Nodule71083.064329.244455.8617
C2732Product temperature excursion issue12949.57892773.76925518.3292
AHBVB986Injection site haemorrhage3902.857215.81878.5413
9H2H2Nuclear magnetic resonance imaging brain abnormal3859.71431718.42861443.558
AHBVB448AAHepatitis B antigen positive3694.1154925.1538960.8669
9H2H2Electroencephalogram abnormal3622.55171244.10341102.9664
M2DK9Off label use7600.33261884.61672818.6867
1491YApnoea3587.86981957.23261172.5391
AHBVA077ABTherapeutic response decreased3587.86981957.23261172.5391
H010269Off label use6545.72791557.36542241.5657
J007946Drug dose omission4500.6944572.0794784.9651
K004810Dyspepsia3459.4545673.4748.5025
R022122Inflammation7458.92371832.69492347.7818

Canada Vigilance (Health Canada)

283 unique reports · 1,010 reaction mentions · 70.7% serious (200 of 283 reports). Top categories: Other / Unclassified (220), Neurological (199), General / Systemic (non-local) (114).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

4 unique reports · 7 reaction mentions · 0.0% serious (0 of 4 reports). Top categories: Allergic / Anaphylactic (3), Gastrointestinal (2), General / Systemic (non-local) (2).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

No EudraVigilance summary mapped for this vaccine.

MMR

15,825 VAERS lot-attributed reports | 2177 lots | 241 flagged

VAERS (United States) — full lot IDs

MMR — Merck

7,989 reports | 1059 lots | 135 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
L012479780.0%011.1VOL
L003855520.0%07.0VOL
L049314462.2%06.0VOL
M001200450.0%05.9VOL
L026553440.0%05.7VOL
J016232424.8%05.4VOL
K016154402.5%05.1VOL
T033814400.0%05.1VOL
W031980400.0%05.1VOL
K021151390.0%05.0VOL
K024036360.0%04.5VOL
L012482350.0%04.3VOL

MMRV (ProQuad) — Merck

7,421 reports | 1066 lots | 104 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
U015479680.0%09.2VOL
K025766670.0%09.1VOL
L030586620.0%08.3VOL
W002782600.0%08.0VOL BURST
L002419452.2%05.8VOL
W002783450.0%05.8VOL BURST
L007230420.0%05.3VOL
L032761380.0%04.7VOL
X018574380.0%04.7VOL
M044718370.0%04.5VOL
N013865350.0%04.2VOL
K014798340.0%04.1VOL

MMR — Glaxosmithkline Biologicals

340 reports | 42 lots | 1 flagged · showing 1

Lot IDReportsSerious%DeathszFlags
4N222540.0%05.5VOL

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
X023876Product distribution issue618837.046044.55568037.5156
0226UNo adverse effect33986.531885.05535.6247
W035470Product expiration date issue42657.333310626.33334881.0555
W029552Interchange of vaccine products4975.24491240.94811390.8127
U015479Poor quality product administered13680.5714842.94692110.807
T025507Product temperature excursion issue10451.65592344.41053147.2652
0776YMumps5397.62131020.88341386.2424
0776YParotitis5319.4007819.74471147.4924
S007813Accidental exposure to product6217.1027339.2477878.5459
0297UInjection site cellulitis3207.0303.1333365.0301
WO20547Incorrect dose administered26199.58993708.0113782.2694
Y010046Syringe issue3191.0856338.93361.1684
S013711Influenza virus test negative3163.1082229.8586288.0817
0831ZFeeling hot3151.2304361.5528307.8359
T021639Product temperature excursion issue3142.8592209.0601258.1029

Canada Vigilance (Health Canada)

1,219 unique reports · 4,089 reaction mentions · 51.4% serious (627 of 1,219 reports). Top categories: General / Systemic (non-local) (845), Other / Unclassified (730), Dermatological (non-injection-site) (591).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

1,132 unique reports · 1,603 reaction mentions · 3.5% serious (40 of 1,132 reports). Top categories: Neurological (828), Other / Unclassified (282), General / Systemic (non-local) (128).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

47,233 individual cases (up to 28/06/2026) · MEASLES, MUMPS AND RUBELLA VACCINE (LIVE). Reaction SOC breakdown not included in this DAP export.

Individual-case totals from adrreports.eu DAP exports in EudraVigilance/. Reaction SOC breakdown not included in these workbooks. Lot/batch numbers are not available.

Search EudraVigilance →

Meningococcal

10,269 VAERS lot-attributed reports | 1367 lots | 154 flagged

VAERS (United States) — full lot IDs

MNQ — Sanofi Pasteur

3,234 reports | 538 lots | 104 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
U5416AA2231.8%04.4VOL
U6365AA220.0%04.4VOL
U5833AA210.0%04.2VOL
U5948AB214.8%04.2VOL
U6952AA210.0%04.2VOL
U6016AA200.0%03.9VOL
U6220AA1910.5%03.6VOL
U6346AA1811.1%03.3VOL
U6179AA170.0%03.0VOL
U6208AB170.0%03.0VOL
U6921AA170.0%03.0VOL
U8361AA170.0%03.0VOL

MNQ — Novartis Vaccines And Diagnostics

2,904 reports | 461 lots | 29 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
M12100402.5%08.2VOL
M14071277.4%05.0VOL
A11082267.7%04.8VOL
M12102230.0%04.1VOL
A100472123.8%03.6VOL
AMVA569A210.0%03.6VOL
M110822015.0%03.3VOL
AMXA5H94100.0%00.9BURST
AMVA926A80.0%00.4BURST
M10200680.0%00.4BURST
09100170.0%00.2BURST
AMVA440A70.0%00.2BURST

MENB — Novartis Vaccines And Diagnostics

2,564 reports | 211 lots | 8 flagged · showing 8

Lot IDReportsSerious%DeathszFlags
TH9NR400.0%03.6VOL
G7KX2370.0%03.3VOL
16D401147.1%00.2BURST
157101A1154.5%0-0.1SER
169701A837.5%0-0.5BURST
ABX749AA70.0%0-0.7BURST
ABXA86AZ60.0%0-0.8BURST
15C601A366.7%0-1.2SER

MENB — Pfizer/Wyeth

1,213 reports | 126 lots | 5 flagged · showing 5

Lot IDReportsSerious%DeathszFlags
J28923466.5%04.9VOL
J292034311.6%04.5VOL
AL846890.0%0-0.1BURST
AM686760.0%0-0.5BURST
R65026366.7%0-0.9SER

MEN

105 reports | 19 lots | 4 flagged · showing 4

Lot IDReportsSerious%DeathszFlags
U7945BB100.0%02.0BURST
U7576AB80.0%01.1BURST
UJ975AA70.0%00.7BURST
U8493AA60.0%00.2BURST

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
AMVA207AProduct packaging confusion33991.94449579.26673206.8744
S56024Capillary nail refill test31994.80562815.78431455.7949
16D501Adverse reaction7565.53311063.65051920.9196
AMVA206AExtensive swelling of vaccinated limb3544.46214348.6971123.3985
AMXA5H94Product administration error3197.8512289.7152333.7565
X14031Product reconstitution issue3190.0926454.8222373.973
AMVA993ASingle component of a two-component product administered3177.3679289.602316.9436
M12100Incorrect storage of drug25174.3167459.45072502.0041
0900901Drug administration error4155.5303619.1212470.3804
A10135Vaccination site swelling3148.1691491.5636311.3005
U4556ABIncorrect storage of drug9132.5735410.3397925.344
U7449ABPoor quality product administered7131.4487224.6264644.9748
M12102Incorrect storage of drug14130.3346327.74021317.8443
M10030Drug administration error5116.3619257.3597429.5863
DW2999Product administration error3114.4561140.0753183.3578

Canada Vigilance (Health Canada)

455 unique reports · 2,096 reaction mentions · 37.8% serious (172 of 455 reports). Top categories: Other / Unclassified (494), General / Systemic (non-local) (298), Injection-site / Local reaction (248).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

No JADER summary mapped for this vaccine.

EudraVigilance (EU)

No EudraVigilance summary mapped for this vaccine.

Rotavirus

5,886 VAERS lot-attributed reports | 732 lots | 117 flagged

VAERS (United States) — full lot IDs

RotaTeq (RV5) — Merck

5,525 reports | 663 lots | 114 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
K014826831.2%07.8VOL
L013202720.0%06.6VOL
1660991690.0%06.3VOL
L000571690.0%06.3VOL
L008053610.0%05.5VOL
S006050560.0%05.0VOL
L008057550.0%04.8VOL
M039067530.0%04.6VOL BURST
K023532520.0%04.5VOL
K023157500.0%04.3VOL
L046319490.0%04.2VOL
J007283460.0%03.9VOL

Rotarix (RV1) — Glaxosmithkline Biologicals

309 reports | 59 lots | 5 flagged · showing 5

Lot IDReportsSerious%DeathszFlags
5N2AN147.1%03.1VOL
KB7FJ140.0%03.1VOL
SKBYL9YN110.0%02.0BURST
5RZ7F60.0%00.3BURST
A41CB44644100.0%0-0.4SER

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
0145FInfection transmission via personal contact45290.29617.72732000.297
SKBYL9YNProduct complaint113754.111190075.66674914.3546
KB7FJSingle component of a two-component product administered41174.61677.57141026.3729
SKBYL9YNAccidental underdose111023.848524549.36363683.0166
1742077Poor quality product administered3936.09097481.72731530.6761
A41CB4464Wrong technique in drug usage process3549.081827.9333916.874
M022373Product quality issue3549.081827.9333916.874
0410FNo adverse effect3345.9412690.8824553.9966
SKBYL9YNRegurgitation11250.27415983.57781780.0395
0515ZScreaming3187.21821490.7455406.0407
1707457Product temperature excursion issue3141.8828217.7427236.5109
H395HProduct preparation issue3130.34181035.7342289.1956
0777FMedication error4125.9143200.8629306.8417
YH345Incorrect route of product administration3121.1412962.1294269.7214
1691301Product temperature excursion issue5103.1888132.0113285.1885

Canada Vigilance (Health Canada)

65 unique reports · 187 reaction mentions · 84.6% serious (55 of 65 reports). Top categories: Other / Unclassified (60), Gastrointestinal (52), Thrombotic / Hematological (16).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

1,217 unique reports · 2,763 reaction mentions · 0.7% serious (8 of 1,217 reports). Top categories: Gastrointestinal (1,267), Other / Unclassified (1,016), General / Systemic (non-local) (207).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

No EudraVigilance summary mapped for this vaccine.

Hib

3,064 VAERS lot-attributed reports | 427 lots | 33 flagged

VAERS (United States) — full lot IDs

HIBV — Merck

2,062 reports | 229 lots | 24 flagged · showing 12

Lot IDReportsSerious%DeathszFlags
S023645990.0%07.4VOL BURST
K016965960.0%07.2VOL
J016188760.0%05.5VOL
K008874660.0%04.7VOL BURST
W006721240.0%01.2BURST
T020616200.0%00.9BURST
R0123571180.0%00.7BURST
R001085160.0%00.6BURST
U026217160.0%00.6BURST
T026067100.0%00.1BURST
T042013100.0%00.1BURST
L00474090.0%00.0BURST

HIBV — Sanofi Pasteur

787 reports | 151 lots | 6 flagged · showing 6

Lot IDReportsSerious%DeathszFlags
UK010AA200.0%05.2VOL
UJ863AA170.0%04.1VOL
UJ649AAA100.0%01.7BURST
UJ854AA70.0%00.6BURST
UK363AA70.0%00.6BURST
UI969AAB60.0%00.3BURST

HIBV — Glaxosmithkline Biologicals

187 reports | 42 lots | 5 flagged · showing 5

Lot IDReportsSerious%DeathszFlags
242A7120.0%03.0VOL
594CF110.0%02.6BURST
AHIBC263BA100.0%02.2BURST
BA97580.0%01.4BURST
Y24T960.0%00.6BURST

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
UH523AAIncorrect drug dosage form administered51602.33337473.88891721.2463
UK233AADermatitis diaper3857.082854.6955.3106
2S27KInjection site discolouration3412.19233290.5385707.0351
UK233AAMusculoskeletal stiffness3329.64621096.4872529.1995
Y24T9Product complaint5253.01177.0734.4578
W002453Accidental underdose3251.0941315.9333236.0167
0419AEInjection site nodule4204.06672031.6667548.7498
0655RInjection site nodule3184.77591471.2069372.9391
Y24T9Exposure via skin contact3179.9412358.8824286.7621
Y24T9Needle issue3161.0321.0262.536
0063UInjection site mass3144.82431151.5946301.3472
UI719AAAInappropriate schedule of drug administration3140.8289249.5848224.3931
0063UInjection site pain3137.39741092.1795287.517
AHIBC263BAUnevaluable event10129.60612830.3333856.9659
0063UInjection site warmth3124.6163989.9302263.314

Canada Vigilance (Health Canada)

17 unique reports · 34 reaction mentions · 82.3% serious (14 of 17 reports). Top categories: Other / Unclassified (11), Dermatological (non-injection-site) (7), Autoimmune / Immune-mediated (4).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

144 unique reports · 193 reaction mentions · 8.3% serious (12 of 144 reports). Top categories: Neurological (52), Other / Unclassified (39), General / Systemic (non-local) (33).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

11,980 individual cases (up to 28/06/2026) · HAEMOPHILUS TYPE B CONJUGATE VACCINE. Reaction SOC breakdown not included in this DAP export.

Individual-case totals from adrreports.eu DAP exports in EudraVigilance/. Reaction SOC breakdown not included in these workbooks. Lot/batch numbers are not available.

Search EudraVigilance →

Hepatitis B

1,416 VAERS lot-attributed reports | 116 lots | 9 flagged

VAERS (United States) — full lot IDs

HEPAB — Glaxosmithkline Biologicals

1,407 reports | 114 lots | 8 flagged · showing 8

Lot IDReportsSerious%DeathszFlags
4F3YY621.6%04.9VOL
2KE55460.0%03.3VOL
P2443454.4%03.2VOL
AHABB223CA966.7%0-0.3SER
AHABB068AA862.5%0-0.4SER
AHABB189AB757.1%0-0.5SER
AHABB244AA757.1%0-0.5SER
AHABA026AA475.0%0-0.8SER

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
H3SG9Accidental underdose3390.04453.3721120.2562
AHABB030AAMedication error4201.2857401.5714306.0228
AHABB223DAHepatitis A antibody negative3197.12302.7231193.6083
AHABB223DAHepatitis B antibody positive3140.8216.0769160.6242
H3SG9Underdose3130.0133151.015589.0111
H3SG9Product complaint378.00890.544270.2697
H3SG9Syringe issue343.337850.2348.8629
P2443Blood glucose decreased341.756545.112935.7506
AHABB204BAOropharyngeal pain328.882741.894645.1832
2BA47Peripheral swelling324.206931.942535.9592
797K7Unevaluable event324.206931.942535.9592
AHABB167BAThroat tightness323.433332.670636.1705
H7RF2Product storage error421.215423.852236.0322
324BYProduct administered to patient of inappropriate age1216.388231.7765129.4581
M4B34Extra dose administered413.313916.309227.0983

Canada Vigilance (Health Canada)

189 unique reports · 658 reaction mentions · 45.0% serious (85 of 189 reports). Top categories: Other / Unclassified (110), Neurological (102), General / Systemic (non-local) (94).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

175 unique reports · 292 reaction mentions · 4.0% serious (7 of 175 reports). Top categories: Other / Unclassified (56), General / Systemic (non-local) (55), Neurological (48).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

16,807 individual cases (up to 28/06/2026) · HEPATITIS B VACCINE (RDNA). Reaction SOC breakdown not included in this DAP export.

Individual-case totals from adrreports.eu DAP exports in EudraVigilance/. Reaction SOC breakdown not included in these workbooks. Lot/batch numbers are not available.

Search EudraVigilance →

Polio (IPV)

1,318 VAERS lot-attributed reports | 100 lots | 5 flagged

VAERS (United States) — full lot IDs

IPV (polio) — Sanofi Pasteur

1,314 reports | 100 lots | 6 flagged · showing 6

Lot IDReportsSerious%DeathszFlags
W1C751M920.0%05.5VOL
J13821480.0%02.4BURST
P1A461M70.0%0-0.4BURST
PIF541M70.0%0-0.4BURST
A0298616.7%0-0.5BURST
M14771M560.0%0-0.6SER

Disproportionality signals (PRR)

Lot IDReactionCasesPRRRORχ²
A0298Injection site discolouration5412.65711922.0667632.7217
J13821Incorrect storage of drug48351.971411700.04761185.077
A0298Immediate post-injection reaction3145.8889290.7778193.0624
W1B511MNasopharyngitis371.077.363646.9517
M14771MInjection site swelling463.5806251.3226166.0391
Y1A212MFall334.363640.059940.8655
W1C741MCircumstance or information capable of leading to medication error329.031.419828.167
M14771MInjection site erythema427.0105.076.4817
R1F801MProduct administered to patient of inappropriate age323.121232.229935.3734
Y1D03P1Injection site pain313.267416.702318.7047
K1649Pyrexia311.883727.120920.9861
Y1A212MInappropriate schedule of product administration59.737712.335425.8929
U1A452MIncorrect dose administered36.57587.92167.6823
U1C571MIncorrect dose administered35.90916.95046.4565
T1E87Medication error35.576337.610210.2604

Canada Vigilance (Health Canada)

4 unique reports · 7 reaction mentions · 100.0% serious (4 of 4 reports). Top categories: Neurological (2), Other / Unclassified (2), Cardiac / Cardiovascular (1).

Product-level spontaneous reports from the CV Online public extract. Lot/batch numbers are not included in this dataset, so lot signal detection is not available for Canada. Reports are unverified temporal associations.

Search Canada Vigilance →

JADER (PMDA, Japan)

49 unique reports · 66 reaction mentions · 22.4% serious (11 of 49 reports). Top categories: Neurological (28), Other / Unclassified (11), General / Systemic (non-local) (7).

Product-level spontaneous reports from the JADER public CSV extract (pmdacasereport202606). Lot/batch numbers are not included. Reports are unverified temporal associations. JADER reference (PDF)

Search JADER / PMDA adverse reactions →

EudraVigilance (EU)

No EudraVigilance summary mapped for this vaccine.

Methods & Limitations

VAERS volume z-score: within-vaccine standardization; z ≥ 3 flagged. Full lot IDs from VAX_LOT.
Disproportionality: PRR ≥ 2, χ² ≥ 4, ≥ 3 cases (lot vs other lots, same vaccine).
O/E: vaccine-wide serious background; no lot-specific denominators.
Canada Vigilance: Health Canada CV Online extract — product-level reaction mentions; no lot/batch field in public data.
Multi-vaccine reports excluded from VAERS lot analysis.

Pipelines: vaers_lot_pipeline.py, canada_vigilance_pipeline.py · Source: vaers_lot_output/vaers_lot_summary.json · Permalink: #vax-mmr

Data Schemas

JSON Schema (draft 2020-12) for pipeline artifacts. Catalog: schemas/catalog.json

ArtifactFormatLocationSchema
Pharmacovigilance lot dashboard (static HTML)
Pre-rendered lot tables, Canada Vigilance blocks, and PV systems overview
HTMLvaers-lot-dashboard.htmlvaers_lot_summary.schema.json
VAERS lot summary
Source for dashboard generation and vaccine page lot embeds
JSONvaers_lot_output/vaers_lot_summary.jsonvaers_lot_summary.schema.json
VAERS lot pipeline manifest
Provenance, year-level quality gates
JSONvaers_lot_output/vaers_lot_manifest.jsonvaers_lot_manifest.schema.json
VAERS lot cases
Underlying case-level lot attribution (not rendered directly)
Parquetvaers_lot_output/vaers_lot_cases.parquetvaers_lot_cases.parquet.schema.json
VAERS lot events
Disproportionality input (lot × MedDRA PT)
Parquetvaers_lot_output/vaers_lot_events.parquetvaers_lot_events.parquet.schema.json
VAERS lot summary table
Aggregated lot metrics feeding vaers_lot_summary.json
Parquetvaers_lot_output/vaers_lot_summary_table.parquetvaers_lot_summary_table.parquet.schema.json
VAERS disproportionality signals
PRR/ROR tables on dashboard and in summary JSON
Parquetvaers_lot_output/vaers_lot_signals.parquetvaers_lot_signals.parquet.schema.json
Canada Vigilance category data
Canada Vigilance panels (product-level; no lot field)
JSONcanada_vigilance_category_data.jsoncanada_vigilance_category_data.schema.json
JADER (PMDA, Japan) category data
JADER panels and AE pie charts (product-level; no lot field)
JSONpmda_category_data.jsoncanada_vigilance_category_data.schema.json
EudraVigilance (EU) case data
EudraVigilance panels and surveillance grid (case counts from DAP xlsx; no lot field)
JSONeudravigilance_category_data.jsoncanada_vigilance_category_data.schema.json
Pharmacovigilance system registry
Systems comparison table on dashboard and vaccine pages
JSON (embedded)lot_pharmacovigilance.py → LOT_DATA.pvSystemspharmacovigilance_system.schema.json
Dashboard CSV export
User-exported subset of topLots
CSVClient download (vaers_lot_signals.csv)vaers_lot_csv_export.schema.json
Vaccine page lot HTML block
Per-vaccine Section 3 lot tables + Canada Vigilance context
HTML (logical JSON)*-vaccine.html#vaers-lot-signals-tablevaccine_page_lot_embed.schema.json
Vaccine product composition (package-insert ingredients)
Ingredient tags on vaccine pages; reverse index for ingredients/pages/*; structured antigen/adjuvant/excipient/preservative/encapsulation/delivery data
JSONingredients/vaccine_product_composition.jsonvaccine_product_ingredients.schema.json
Active pharmacovigilance records (defined-population surveillance)
Active Pharmacovigilance pane in Section 3 of each *-vaccine.html (after passive VAERS block)
JSONactive_pharmacovigilance_data.jsonactive_pharmacovigilance.schema.json
Vaccine development pipeline candidates
vaccine-pipeline.html dashboard
JSONvaccine_pipeline_data.jsonvaccine_pipeline.schema.json
COVID-19 vaccine injury table (strict WHO causality criteria)
vaccine-pipeline/injury-tables/index.html (strict tab)
JSONcovid_injury_table_strict.jsoninjury_table.schema.json
Rank-aggregated VAERS signals (rankv)
Section 4 of each *-vaccine.html (rankv signal table)
JSONrankv_signals.json—
Adverse event biological mechanisms catalog
Causality assessment section on each *-vaccine.html
JSONae_mechanisms_catalog.jsonae_mechanism.schema.json
Per-vaccine WHO causality + mechanism injury tables
integrate_injury_tables_to_pages.py → all vaccine pages
JSONvaccine-pipeline/injury-tables/vaccine_injury_table_*.jsonvaccine_injury_table.schema.json
ICAN/OpenVAERS licensure trial design (No Placebo Table)
Section 2 of each *-vaccine.html (comparator / placebo-use table)
JSONvaccine_licensure_trial_design.json—
COVID-19 vaccine injury table (loosened WHO causality criteria)
vaccine-pipeline/injury-tables/index.html (loosened tab)
JSONcovid_injury_table_loosened.jsoninjury_table.schema.json